Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
6,681 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00658437 | CY503 for the Treatment of Malignant Melanoma Stage IV After Failure of Prior Therapy | completed | Phase 2 | 31 | Cytavis Biopharma GmbHINDUSTRY | 1 | Jun 8, 2011 | clinicaltrials |
| NCT01259518 | Dose Escalation Study of TriN2755 in Advanced Solid Tumors and Sarcomas | unknown | Phase 1 | 48 | Trin Therapeutics GmbHINDUSTRY | 1 | Jun 8, 2011 | clinicaltrials |
| NCT00041587 |
| Pre-operative IL13-PE38QQR in Patients With Recurrent or Progressive Malignant Glioma |
| completed |
| Phase 1 / Phase 2 |
| 80 |
| INSYS Therapeutics IncINDUSTRY |
| 3 |
| Jun 6, 2011 |
| clinicaltrials |
| NCT00076986 | The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme | completed | Phase 3 | 300 | INSYS Therapeutics IncINDUSTRY | 6 | Jun 6, 2011 | clinicaltrials |
| NCT00325234 | Pemetrexed-Carboplatin and Gemcitabine-Vinorelbine in Advanced Breast Cancer | completed | Phase 2 | 135 | Eli Lilly and CompanyINDUSTRY | 5 | May 20, 2011 | clinicaltrials |
| NCT00521664 | A Trial Comparing a Prophylactic With a Therapeutic Platelet Transfusion Strategy in Two Groups | completed | Phase 3 | 400 | Technische Universität DresdenOTHER | 1 | May 19, 2011 | clinicaltrials |
| NCT00322517 | Study Of The Efficacy And Safety Of SU-014813 In Patients With Metastatic Breast Cancer | completed | Phase 2 | 90 | PfizerINDUSTRY | 5 | May 17, 2011 | clinicaltrials |
| NCT00076388 | Iressa Versus Docetaxel (Taxotere) | completed | Phase 3 | 1,440 | AstraZenecaINDUSTRY | 25 | May 13, 2011 | clinicaltrials |
| NCT01343264 | Trimodality Therapy for Malignant Pleural Mesothelioma | unknown | — | 200 | HSK WiesbadenOTHER | 1 | Apr 28, 2011 | clinicaltrials |
| NCT00154375 | Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma | completed | Phase 3 | 240 | Novartis PharmaceuticalsINDUSTRY | 1 | Apr 26, 2011 | clinicaltrials |
| NCT01332773 | The ARTERY FIRST Approach for Resection of Pancreatic Head Cancer(Artery first) | unknown | Phase 3 | 124 | Heidelberg UniversityOTHER | 1 | Apr 19, 2011 | clinicaltrials |
| NCT00006479 | Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer | unknown | Phase 3 | — | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 13 | Apr 18, 2011 | clinicaltrials |
| NCT00101647 | Study of Dasatinib (BMS-354825) in Patients With Accelerated Phase Chronic Myeloid Leukemia | completed | Phase 2 | 197 | Bristol-Myers SquibbINDUSTRY | 23 | Apr 15, 2011 | clinicaltrials |
| NCT00101595 | Dasatinib (BMS-354825) in Subjects With Lymphoid Blast Phase Chronic Myeloid Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia | completed | Phase 2 | 96 | Bristol-Myers SquibbINDUSTRY | 20 | Apr 14, 2011 | clinicaltrials |
| NCT00179621 | Lenalidomide Versus Placebo in Myelodysplastic Syndromes With a Deletion 5q[31] Abnormality | completed | Phase 3 | 205 | Celgene CorporationINDUSTRY | 9 | Apr 14, 2011 | clinicaltrials |
| NCT01322854 | Adjuvant Whole Breast Radiotherapy (RT) With Intensity Modulated Radiotherapy (IMRT) and a Simultaneous Integrated Boost Versus Conventional RT and a Sequential Boost(IMRT-MC2) | unknown | Phase 3 | 502 | Heidelberg UniversityOTHER | 1 | Apr 7, 2011 | clinicaltrials |
| NCT01330823 | L-CARnitine in the Palliative Treatment of Advanced PANcreatic Cancer (CARPAN)(CARPAN) | suspended | Phase 3 | 72 | University Medicine GreifswaldOTHER | 1 | Apr 7, 2011 | clinicaltrials |
| NCT00540241 | Performance Status During Treatment With Pemetrexed in Patients With NSCLC(PERFORMANCE) | completed | — | 542 | Eli Lilly and CompanyINDUSTRY | 1 | Mar 29, 2011 | clinicaltrials |
| NCT00372567 | Safety And Effectiveness Of Daily Dosing With Sunitinib Or Imatinib In Patients With Gastrointestinal Stromal Tumors | terminated | Phase 3 | 69 | PfizerINDUSTRY | 7 | Mar 17, 2011 | clinicaltrials |
| NCT01128465 | Pharmacokinetic and -Dynamic of Propofol During Awake Craniotomy | completed | — | 10 | University Hospital, BonnOTHER | 1 | Mar 17, 2011 | clinicaltrials |
| NCT01170052 | Bendamustine and Temsirolimus in Patients With Relapsed or Refractory Mantle Cell Non-Hodgkin's Lymphoma (NHL) | withdrawn | Phase 1 / Phase 2 | 20 | Charite University, Berlin, GermanyOTHER | 1 | Mar 16, 2011 | clinicaltrials |
| NCT00433095 | Vinorelbine (Oral) Plus Trastuzumab for 1st-line Treatment of HER2/Neu Overexpressing Breast Cancer | completed | Phase 2 | — | Ludwig-Maximilians - University of MunichOTHER | 1 | Mar 14, 2011 | clinicaltrials |
| NCT01249638 | Cap+Bev vs Cap+Iri+Bev 1st-line Therapy in mCRC | unknown | Phase 3 | 516 | Ludwig-Maximilians - University of MunichOTHER | 1 | Mar 14, 2011 | clinicaltrials |
| NCT00417079 | XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone in Hormone Refractory Metastatic Prostate Cancer(TROPIC) | completed | Phase 3 | 755 | SanofiINDUSTRY | 26 | Mar 10, 2011 | clinicaltrials |
| NCT00496067 | Uterine Artery Occlusion for Fibroid Related Bleeding | terminated | N/A | 91 | Ethicon, Inc.INDUSTRY | 7 | Mar 9, 2011 | clinicaltrials |
| NCT00983138 | Efficacy and Safety of Recombinant Asparaginase in Infants With Previously Untreated Acute Lymphoid Leukemia (ALL) | completed | Phase 2 | 12 | medac GmbHINDUSTRY | 2 | Mar 1, 2011 | clinicaltrials |
| NCT01302951 | Penetration of Moxifloxacin Into Liver Tissue of Patients Undergoing Liver Resection.(MOXI) | completed | Phase 4 | 34 | University Hospital, SaarlandOTHER | 1 | Feb 24, 2011 | clinicaltrials |
| NCT00148876 | TBP Study With Capecitabine Plus Minus Trastuzumab | completed | Phase 3 | 482 | GBG Forschungs GmbHOTHER | 1 | Feb 23, 2011 | clinicaltrials |
| NCT01300663 | A New Patient Reported Outcome Instrument to Assess Symptom Experience in Women With Vulvar Neoplasms (WOMAN-PRO)(WOMAN-PRO) | unknown | — | 150 | University of BaselOTHER | 2 | Feb 23, 2011 | clinicaltrials |
| NCT01140555 | A Pilot Study to Determine Optimal Procedure Steps to Obtain and Maintain Uterine Artery Occlusion With the D-UAO Device | terminated | N/A | 2 | Ethicon, Inc.INDUSTRY | 4 | Feb 17, 2011 | clinicaltrials |
| NCT00688740 | Docetaxel in Node Positive Adjuvant Breast Cancer(TAX316) | completed | Phase 3 | 1,491 | SanofiINDUSTRY | 20 | Feb 16, 2011 | clinicaltrials |
| NCT00368420 | Validation of a Score of Predictive Factors for Complete Resection in Platinum-sensitive Recurrent Ovarian Cancer | completed | — | 122 | AGO Study GroupOTHER | 4 | Feb 15, 2011 | clinicaltrials |
| NCT01076751 | Observational Registry of Treatment Patterns in Castrate-resistant Prostate Cancer (CRPC) Patients(PORTREAT) | terminated | — | 82 | SanofiINDUSTRY | 5 | Feb 14, 2011 | clinicaltrials |
| NCT00779688 | A Registry of Patients Undergoing Cellvizio Endomicroscopy and Endoscopic Retrograde Cholangiopancreatography(ERCP) Imaging Procedures for Diagnosing Pancreatic and Bile Duct Cancers | completed | — | 130 | Mauna Kea TechnologiesINDUSTRY | 3 | Feb 10, 2011 | clinicaltrials |
| NCT00930475 | Everolimus (RAD001) and Carboplatin in Pretreated Metastatic Breast Cancer | unknown | Phase 1 / Phase 2 | 54 | Charite University, Berlin, GermanyOTHER | 1 | Jan 26, 2011 | clinicaltrials |
| NCT00501605 | Phase I Study With AZD2171 in Patients With Advanced Solid Malignant Tumors and Liver Metastases | completed | Phase 1 | 80 | AstraZenecaINDUSTRY | 1 | Jan 21, 2011 | clinicaltrials |
| NCT00401323 | Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma | completed | Phase 2 / Phase 3 | 568 | SanofiINDUSTRY | 20 | Jan 20, 2011 | clinicaltrials |
| NCT00411151 | Efficacy and Safety of Sunitinib in Metastatic Gastric Cancer | completed | Phase 2 | 52 | Johannes Gutenberg University MainzOTHER | 1 | Jan 20, 2011 | clinicaltrials |
| NCT00786552 | Pemetrexed + Paclitaxel in Patients With Recurrent/Advanced Thyroid Cancer(Panthera) | unknown | Phase 2 | 47 | University Hospital Schleswig-HolsteinOTHER | 1 | Jan 20, 2011 | clinicaltrials |
| NCT01054937 | Single Dose Study With 4SC-203 in Healthy Volunteers | completed | Phase 1 | 60 | 4SC AGINDUSTRY | 1 | Jan 13, 2011 | clinicaltrials |
| NCT00623402 | Combined Treatment of Sorafenib and Pegylated Interferon α2b in Stage IV Metastatic Melanoma(SoraPeg) | completed | Phase 2 | 55 | University Hospital Schleswig-HolsteinOTHER | 1 | Jan 12, 2011 | clinicaltrials |
| NCT00661609 | A Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder Cancer | completed | Phase 2 | 54 | AstraZenecaINDUSTRY | 5 | Jan 12, 2011 | clinicaltrials |
| NCT01274689 | External Lid Loading for the Temporary Treatment of the Paresis of the M. Orbicularis Oculi: a Clinical Note | completed | — | 152 | Charite University, Berlin, GermanyOTHER | 1 | Jan 11, 2011 | clinicaltrials |
| NCT00268892 | Extension Study Investigating the Long-Term Safety of Degarelix Three-Month Depots in Patients With Prostate Cancer | completed | Phase 2 / Phase 3 | 278 | Ferring PharmaceuticalsINDUSTRY | 10 | Dec 24, 2010 | clinicaltrials |
| NCT00357110 | Anastrozole and Fulvestrant Compared to Anastrozole as Adjuvant Treatment of Postmenopausal Patients With Breast Cancer(@FAME) | completed | Phase 2 | 13 | AstraZenecaINDUSTRY | 3 | Dec 21, 2010 | clinicaltrials |
| NCT01252459 | Amino-acid PET Versus MRI Guided Re-irradiation in Patients With Recurrent Glioblastoma Multiforme(GLIAA) | unknown | Phase 2 | 200 | University Hospital FreiburgOTHER | 1 | Dec 16, 2010 | clinicaltrials |
| NCT00116753 | A Comparative Study of Degarelix Three-month Depot in Three Different Dosing Regimens in Patients With Prostate Cancer | completed | Phase 2 | 460 | Ferring PharmaceuticalsINDUSTRY | 11 | Dec 10, 2010 | clinicaltrials |
| NCT00673205 | (Bicalutamide) Casodex vs Placebo in Non-metastatic Early Prostate Cancer(Capri) | completed | Phase 3 | 3,588 | AstraZenecaINDUSTRY | 16 | Dec 10, 2010 | clinicaltrials |
| NCT00829192 | Phase II AK Study in Organ Transplant Patients | unknown | Phase 2 | 200 | Clinuvel Pharmaceuticals LimitedINDUSTRY | 7 | Dec 6, 2010 | clinicaltrials |
Data updated 24 days agoSource updated unknownsource: clinicaltrials